Investment Summary

Andera Partners Invests In Medical Microinstruments

On April 18, 2018, private equity firm Andera Partners invested in life science company Medical Microinstruments

Investment Highlights
  • This is Andera Partners’ 13th transaction in the Life Science sector.
  • This is Andera Partners’ 3rd transaction in Italy.

Investment Summary

Date 2018-04-18
Target Medical Microinstruments
Sector Life Science
Investor(s) Andera Partners
Deal Type Venture

Target

Medical Microinstruments

Pisa, Italy
Medical Microinstruments (MMI) is an Italian company dedicated to improve clinical outcomes for patients undergoing microsurgery. Medical Microinstruments was founded in 2015 and is based in Pisa, Italy.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Andera Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.


DEAL STATS #
Overall 56 of 106
Sector: Life Science M&A 13 of 27
Type: Venture M&A Deals 12 of 28
Country: Italy M&A 3 of 4
Year: 2018 M&A 2 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-15 Soft Company

Paris, France

Soft Company provides IT services, for the banking and finance sector. Soft Company was founded in 1991 and is based in Paris, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-02 Crescendo Biologics

Cambridge, United Kingdom

Crescendo Biologics is a biopharmaceutical company developing potent, truly differentiated humabody therapeutics in oncology with a proprietary pipeline focus on innovative targeted T-cell approaches. Crescendo Biologics was founded in 2009 and is based in Cambridge, United Kingdom.

Buy -